[1]
Вісич, С.Ю., Русанова, С.В., Андрюкова, Л.М. and Доровський, О.В. 2016. Primary analysis and prioritization of risks of biowaiver procedure. ScienceRise: Pharmaceutical Science. 2 (2) (Aug. 2016), 51–57. DOI:https://doi.org/10.15587/2519-4852.2016.76466.